5 - 8 February 2024
Dubai World Trade Centre
22 Jan - 22 Feb 2024
The evidence and impact of rapid testing to strengthen the healthcare system and patient care
Abbott
Tuesday 7th February I 14:00 - 18:00
Johannesburg room I Z1.D10
Sessions
Presenters
- Dr. Amilcar Tanuri, MD, PhD, Molecular Virologist, University of Rio de Janeiro, Brazil
- Dr. Hafiz Ahmad, PhD, (Co-chair: UAE National Antimicrobial Stewardship committee) Assistant Professor & Clinical Microbiologist, Department of Medical Microbiology & Immunology, RAK College of Medical Sciences, RAK medical & Health Sciences University, Head of Microbiology & Molecular Division-NGS & Covid lab in-charge, RAK Hospital, Ras Al Khaimah, UAE
- Dr. Manaf Alqahtani, MD, Professor of Medicine, Royal College of Surgeons in Ireland (RCSI), Senior Consultant Infectious Diseases and Clinical Microbiologist, Head of Microbiology Lab and Infection Control Department, Bahrain Defence Force (BDF) Hospital, Bahrain
- Dr. Rogier Hopstaken, MD, PhD, General Practitioner, GP Practice Hapert and Hoogeloon Maastricht University, Netherlands
Moderators
- Dr. Rajeeb Debray, Regional (EEME) Medical Director, Abbott Rapid Diagnostics
- Luis Gonzalez, MD, PhD, Director, Medical and Scientific Affairs, Abbott
Session summary
Healthcare professionals are encouraged to join this clinical and scientific session for updates on the use of Point of Care diagnostics for COVID-19 and Influenza testing in decentralized settings. Investigators and clinical experts will share their research and practical experience with point of care testing. The availability of timely results and its impact on patient management and antimicrobial resistance prevention.
Learning objectives
- Discuss the importance of an early differential diagnosis of COVID-19 and Influenza
- Share study and practical experience with POC testing
- Explore the evidence describing the impact of an early and accurate diagnosis on infection control and antibiotic resistance prevention
Presenters
- Dr. Amilcar Tanuri, MD, PhD, Molecular Virologist, University of Rio de Janeiro, Brazil
- Dr. Orlando Ferreira, MD, PhD, Associate Professor, Federal University of Rio de Janeiro, Brazil
- Mohammed Majam, MBA, Director, Medical Technology, Ezintsha, South Africa
Moderators
- Dr. Rajeeb Debray, Regional (EEME) Medical Director, Abbott Rapid Diagnostics
- Luis Gonzalez, MD, PhD, Director, Medical and Scientific Affairs, Abbott
Session summary
Gaps in diagnostics and monitoring treatment of HIV are perpetuating the epidemic. While progress has been made, barriers to HIV testing remain with failure to identify new cases, missing diagnostic in the acute phase and Lost of follow up, which are impacting the achievement of UNAID's 95/95/95 goals. Increasing knowledge of HIV status is a must. Early detection of individuals in the highly infectious acute phase is a key factor in reducing transmission. A reduction in lost to follow up patients by providing results immediately is a key element in the fight against AIDS. Join this program for insights on rapid, accessible, and accurate testing methods.
Learning objectives
- Review the status of HIV infections, current factors for HIV transmission and diagnostic gaps
- Examine the importance of early detection and treatment
- Describe strategies to enhance screening and improve patient and community outcomes
- Discuss test types and the rationale for rapid 4th generation HIV testing
Presenters
- Dr. Mohamed Farghaly, FRCGP, MRCGP, DMScx, DIH, MBCHB, Professor, Dubai Medical College, Head of Insurance Medical Regulation Dubai Health Insurance Corporation (DHIC), Consultant, Family Medicine & Diabetologist, UAE
- Dr. Najiba M. Abdulrazzaq, FRCP, MRCP, MB. Bch. BAO, Consultant Internist, Head of Medical Department, Al Kuwait Hospital, Dubai, UAE
Moderators
- Dr. Wisam Haddadin, Market Access Director EEMEA, Abbott
Session summary
Healthcare professionals are encouraged to join this Market Access session looking into policy adoption for Point of Care. Our key speakers will share recent successful Point of Care policy change adopted in UAE for respiratory diseases, and the strategy that can be used to implement Point of Care test and treat. The session will focus on the increasing burden of AMR in the Middle East region and how Point of Care can reduce this burden.
Learning objectives
- Understanding the Burden of AMR in the Middle East region
- Creating policies for testing for Infectious diseases
- Need for TEST TARGET TREAT
- Creating clear KPI’s for case management to support better patient outcomes
Company bio
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 113,000 colleagues serve people in more than 160 countries.
Presenters
Dr. Amilcar Tanuri, MD, PhD
Molecular Virologist, University of Rio de Janeiro, Brazil
Dr. Amilcar Tanuri is the head of the Molecular Virology Laboratory, Department of Genetics at the Federal University of Rio de Janeiro. He is actively involved in numerous studies, such as HIV genetic variation and its impact in diagnostics and drug resistance; virology and immune response to SARS-CoV-2 and mRNA vaccine development, and clinical, virological and epidemiological aspect of Zika virus microcephaly. He has a strong background in public health laboratories for molecular techniques for isolation and characterization, nucleic acid detection, quantification and sequencing. Dr. Tanuri also serves as a member of the regulatory committee on HIV diagnostics and serology within the Brazilian Ministry of Health.
Dr. Hafiz Ahmad, PhD
(Co-chair: UAE National Antimicrobial Stewardship committee) Assistant Professor & Clinical Microbiologist, Department of Medical Microbiology & Immunology, RAK College of Medical & Health Sciences University, Head of Mivcrobiology & Molecular Division-NGS & Covid lab in-charge, RAK Hospital, Ras Al Khaimah, UAE
Dr Hafiz Ahmad is an active Medical & Molecular Microbiologist with over 10 years experience, he serves in the capacity of Lecturer, Molecular scientist, Assistant Professor and Clinical Microbiologist from India, USA, Germany & UAE. His Academic Responsibilities are: Teaching Medical Microbiology as Integrative Medical curriculum: Bacteriology, Oral Microbiology, General Immunology, Mycobacteriology, Mycology and Virology including molecular Diagnostics, to various undergraduate students of RAK Medical and Health Sciences University (RAKMHSU). His research interests are: COVID-19, Oral Microbiology, Biofilm, Microbiome, HIV & Tuberculosis, Co-infections, Mycology (Candida) & Parasitology, Antimicrobial Resistance & Antibiotic Stewardship. Publications: >35 scientific publications 20 International conference abstracts 4 Book chapters.
Dr. Manaf Alqahtani, MD
Professor of Medicine, Royal College of Surgeons in Ireland (RCSI), Senior Consultant Infectious Diseases and Clinical Microbiologist, Head of Microbiology Lab and Infection Control Department, Bahrain Defence Force (BDF) Hospital, Bahrain
Dr. Manaf Alqahtani is a North America doubly qualified adult infectious diseases doctor and clinical microbiologist consultant at the Royal Medical Services of the Bahrain Defense Force (BDF). He is an Associate Professor of Medicine and Principal Research Investigator at the Royal College of surgeons in Ireland (Medical University of Bahrain). He has a master’s degree in health care management (MBA) from Tulane University, New Orleans He is a Fellow at Royal College of Physicians in Ireland since June 2019. He has won several awards for his contributions in antimicrobial stewardship program and patient centered care initiatives.
Dr. Mohamed Farghaly, FRCGP, MRCGP, DMScx, DIH, MBCHB
Professor, Dubai Medical College, Head, Insurance Medical Regulation Dubai Health Insurance Corporation (DHIC), Consultant, Family Medicine & Diabetologist, UAE
Dr. Mohamed is a professor at the Dubai Medical College, Consultant and Head of Health Policies for Dubai Health Insurance Corporation (DHIC) DHA. He is also a consulting for Family Medicine and diabetologist. He serves as a member of UAE national diabetes committee, a member of UAE National Cancer Committee and a member of DHA Diabetic Board. He is an accredited trainer and examiner in Family Medicine by the Royal College of General practitioners, UK, and Chairman of Family Medicine Scientific Committee EMA. His education background is FRCGP (UK) MRCGP (UK), DMSc (South Wales) and DIH (Ireland) MBCHB (EG).
Dr. Najiba M. Abdulrazzaq, FRCP, MRCP, MB. Bch. BAO
Consultant Internist, Head of Medical Department, Al Kuwait Hospital, Dubai
Dr. Najiba is an active Medical Consultant Internist heading the Internal Medicine and Cardiology department at Al Kuwait Hospital Dubai in UAE. She is also Head of Infection Prevention and Control committee in Emirates Health Services and a key UAE Focal point for Antimicrobial resistance in the World Health Organization, She sits as Co-Chair of National Antimicrobial Resistance committee in UAE and is also the President of International Conference on Antimicrobial Resistance-ICAMR. Her association also extends to University of Sharjah as the Associate Professor of Faculty of Medicine, University of Sharjah.
Dr. Orlando Ferreira, MD, PhD
Associate Professor Molecular Virology Laboratory, Federal University of Rio de Janeiro, Brazil
Dr. Orlando Ferreira has obtained his MD and PhD from Rio de Janeiro, Brazil. He is currently the Associate Professor at the Molecular Virology Laboratory, Genetics Department, at the Federal University of Rio de Janeiro. Previously he has held multiple researcher roles and consultant roles, specifically with the Brazilian STD/AIDS National Program, Ministry of Health from 1999-2019. He currently holds over 100 peer-reviewed publications and is a principal investigator on multiple clinical studies.
Dr. Rogier Hopstaken, MD, PhD
General Practitioner, GP Practice Hapert and Hoogeloon Maastricht University, Netherlands
Dr. Rogier Hopstaken is a practicing general practitioner, and an innovation specialist at Star-Shl diagnostic centers (Etten-Leur, the Netherlands), a cooperation delivering diagnostic services to over 2.000 doctors in the Netherlands. As a general practitioner and researcher at Maastricht University, Dr Hopstaken has contributed to numerous research publications and book chapters, particularly in the field of diagnostic testing, lower respiratory tract infections, and C-reactive protein POCT. Until 2018, he was Head of Innovation, member of the General Management team and Chair of the Medical Staff at Saltro diagnostic center, Utrecht.
Mohammed Majam, MBA
Director, Medical Technology, Ezintsha, South Africa
Mohammed Majam is the Head of Medical Technologies at Ezintsha, a division of the Wits Health Consortium at Wits University in Johannesburg, South Africa. His portfolio includes clinical, implementation science, and digital health research, mainly focusing on rapid, point-of-care diagnostics for HIV, Hepatitis C, and COVID-19. Mohammed lead the HIV Self-testing STAR project in South Africa, which oversaw the scale up of HIVST in the country by developing distribution models and linkage mechanisms for the 2.2 million tests provided to the country through UNITAID’s catalytic investment.
